Lifestream seeks to improve cholesterol monitor:
This article was originally published in Clinica
Lifestream Technologies has filed for US FDA premarket clearance to sell a cholesterol monitor that also performs a computed health risk assessment. The Post Falls, Idaho firm recently received a US patent for the technology. The assessment involves inputting certain risk parameters, such as a person's age, weight and blood pressure. The device is then able to provide information such as the risk of myocardial infarction. The company currently markets a line of cholesterol monitors that deliver results within three minutes.